AstraZeneca Withdraws COVID-19 Vaccine Worldwide as Demand Craters

Published: May 08, 2024 By Tristan Manalac

AstraZeneca's San Francisco Office

Pictured: AstraZeneca’s sign on its office in California/iStock, hapabapa

AstraZeneca is voluntarily withdrawing its COVID-19 vaccine Vaxzevria as global demand for coronavirus products continue to decline and it faces growing competition from newer vaccines, according to several media reports.

The British pharma said that the decision to pull Vaxzevria from the global market was due to the “surplus of available updated vaccines” adapted to newer and emerging variants of COVID-19, Reuters reported Tuesday. “This has led to a decline in demand for Vaxzevria, which is no longer being manufactured or supplied,” the company said.

The withdrawal of Vaxzevria also comes more than a week after AstraZeneca admitted in court documents that the vaccine can trigger thrombosis with thrombocytopenia syndrome (TTS), a rare side effect characterized by…
Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks


ADVERTISEMENT — Advertise With Biotech Networks